Michelle Gan
Corporate Officer/Principal bij Malaysian Institute of Accountants
Profiel
Michelle Gan is a member of the Arizona Society of Certified Public Accountants and the Malaysian Institute of Accountants.
She previously worked as a Finance Manager at StemLife Bhd., an Auditor at Deloitte Touche Tohmatsu LLC, a Principal at Malaysian Biotechnology Corp.
Sdn.
Bhd., a Chief Financial Officer at Sentinext Therapeutics Sdn.
Bhd., and a Principal at Neuroweb Sdn.
Bhd.
She obtained her undergraduate degree from the University of Southern Queensland in 1996.
Currently, Ms. Gan holds positions at the Arizona Society of Certified Public Accountants and the Malaysian Institute of Accountants.
Actieve functies van Michelle Gan
| Bedrijven | Functie | Begin |
|---|---|---|
Malaysian Institute of Accountants
 Malaysian Institute of Accountants Other Consumer ServicesConsumer Services Malaysian Institute of Accountants develops, supports and enhances the integrity, status and interests of the profession in Malaysia. It offers educational services to the members. The company is headquartered in Kuala Lumpur, Malaysia. | Corporate Officer/Principal | - |
| Arizona Society of Certified Public Accountants | Corporate Officer/Principal | - |
Eerdere bekende functies van Michelle Gan
| Bedrijven | Functie | Einde |
|---|---|---|
| Neuroweb Sdn. Bhd. | Corporate Officer/Principal | - |
Malaysian Biotechnology Corp. Sdn. Bhd.
 Malaysian Biotechnology Corp. Sdn. Bhd. BiotechnologyHealth Technology Malaysian Biotechnology Corp. Sdn. The private company is based in Kuala Lumpur, Malaysia, and has subsidiaries in Malaysia. Bhd. operates as an economic development agency for the bio-based industry. | Corporate Officer/Principal | - |
Deloitte Touche Tohmatsu LLC
 Deloitte Touche Tohmatsu LLC Miscellaneous Commercial ServicesCommercial Services Deloitte Touche Tohmatsu LLC engages in the provision of accounting services. The company was founded in May 1968 and is headquartered in Tokyo, Japan. | Comptroller/Controller/Auditor | - |
| STEMLIFE BERHAD | Financieel Directeur/CFO | - |
Sentinext Therapeutics Sdn. Bhd.
 Sentinext Therapeutics Sdn. Bhd. BiotechnologyHealth Technology Sentinext Therapeutics Sdn. Bhd. develops vaccines and therapeutics for tropical infectious diseases. Its pharmaceutical research and development focuses on EV71, polio, influenza and dengue diseases. The company was founded by Mary Jane Cardosa and Peter Samuel Wulff in 2009 and is headquartered in Penang, Malaysia. | Financieel Directeur/CFO | - |
Opleiding van Michelle Gan
| University of Southern Queensland | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
StemLife Bhd.
 StemLife Bhd. Medical/Nursing ServicesHealth Services StemLife Bhd. operates as an investment holding company, which engages in the provision of stem cells therapy and stem cell consultancy services. It operates its business through the following segments: Provision of Collection, Testing, Processing and Preservation of UCBSC, UCT & PBSC. The company was founded by Low Su-Shing, Lim Oi Wah, and Aw Tar Choon on December 13, 2001 and is headquartered in Kuala Lumpur, Malaysia. | Health Services |
| Arizona Society of Certified Public Accountants | |
Deloitte Touche Tohmatsu LLC
Deloitte Touche Tohmatsu LLC Miscellaneous Commercial ServicesCommercial Services Deloitte Touche Tohmatsu LLC engages in the provision of accounting services. The company was founded in May 1968 and is headquartered in Tokyo, Japan. | Commercial Services |
Malaysian Biotechnology Corp. Sdn. Bhd.
Malaysian Biotechnology Corp. Sdn. Bhd. BiotechnologyHealth Technology Malaysian Biotechnology Corp. Sdn. The private company is based in Kuala Lumpur, Malaysia, and has subsidiaries in Malaysia. Bhd. operates as an economic development agency for the bio-based industry. | Health Technology |
Sentinext Therapeutics Sdn. Bhd.
Sentinext Therapeutics Sdn. Bhd. BiotechnologyHealth Technology Sentinext Therapeutics Sdn. Bhd. develops vaccines and therapeutics for tropical infectious diseases. Its pharmaceutical research and development focuses on EV71, polio, influenza and dengue diseases. The company was founded by Mary Jane Cardosa and Peter Samuel Wulff in 2009 and is headquartered in Penang, Malaysia. | Health Technology |
| Neuroweb Sdn. Bhd. |
